| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $273K | -30.7% | -15.8% |
| SG&A Expense | $160K | -8.7% | -44.5% |
| Operating Income | -$1.1M | +52.5% | -70.8% |
| Pre-tax Income | -$869K | +82.8% | -35.7% |
| Income Tax | -$3K | — | +0.0% |
| Net Income | -$869K | +82.8% | -35.7% |
| EPS (Basic) | -$0.47 | +65.7% | -235.7% |
| EPS (Diluted) | -$0.47 | +65.7% | -235.7% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Inventory | $1K | -1.8% | — |
| Current Assets | $2.9M | -34.0% | +100.9% |
| Total Assets | $5.0M | -22.9% | +231.7% |
| Current Liabilities | $9.7M | -7.3% | +1129.3% |
| Total Liabilities | $9.7M | -7.3% | +1129.3% |
| Stockholders' Equity | -$4.7M | -18.3% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.6M | -119.5% | — |
| Investing Cash Flow | $943K | +0.0% | — |
| Financing Cash Flow | $4.4M | -0.3% | — |
| -753.8% |